# OnCo record in10018 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/in10018/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "in10018" ;
  schema:name "IN10018"@en ;
  schema:alternateName "IN10018 add on to PLD treatment"@en, "BI 853520"@en ;
  schema:description "IN10018 is an experimental small-molecule drug from InxMed (Shanghai) in phase 3 trials for non-small-cell lung cancer, pancreatic ductal adenocarcinoma and ovarian cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/in10018/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=BI853520>, <https://www.inxmed.com> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/sclc/> ;
  onco:targets <https://onco.cc/targets/fak/> ;
  onco:companies <https://onco.cc/companies/inventisbio/>, <https://onco.cc/companies/inxmed/> ;
  onco:trials <https://onco.cc/trials/nct07174908/>, <https://onco.cc/trials/nct06014528/>, <https://onco.cc/trials/nct06030258/>, <https://onco.cc/trials/nct05551507/>, <https://onco.cc/trials/nct06708663/>, <https://onco.cc/trials/nct05994131/>, <https://onco.cc/trials/nct07441174/>, <https://onco.cc/trials/nct06166836/>, <https://onco.cc/trials/nct05827796/>, <https://onco.cc/trials/nct05379946/> .